The Biotech Capital Compass
The Biotech Capital CompassBiotechnology & ‘Fog of Valuation’ savant
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 170 | Subscribers | Read | hartajsingh1.substack.com |
Curious about how many subscribers The Biotech Capital Compass has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over six million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Video Recap: Why Medical Conference Season Matters for Biotech Investors
Medical conferences are not just scientific gatherings. In biotech, they often become the calendar around which investor attention, clinical data, and company narratives begin to cluster. This free Video Recap revisits our March 2025 Biotec...
The Deal Window: Before the Deal Becomes Obvious
Three private biotech companies, three different ways to reframe risk before broader institutional capital arrives.
Video Companion: Vertex, CRISPR, and The Cost of Survival
This free Video Companion brings together three recent paid Biotech Capital Compass notes: Vertex Pharmaceuticals Part 2, The Cost of Survival Part 2, and CRISPR Therapeutics Part 1.
CRISPR Therapeutics: From First Approval to a Broader Investment Debate
Part 1 of the CRISPR Series: How Casgevy, Vertex, and platform validation are reshaping the investment case.
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Biotech Capital Compass breaks down complex biotech stories into valuation, risk, and narrative frameworks investors can use. Written by Hartaj Singh, a biotech analyst focused on translating innovation into investment reality.
Frequently Asked Questions
How can I access the email archive for The Biotech Capital Compass?
You can find recent issues that have been published by The Biotech Capital Compass on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Biotech Capital Compass have?
To see how many people subscribe to The Biotech Capital Compass, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Biotech Capital Compass?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Biotech Capital Compass as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Biotech Capital Compass?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Biotech Capital Compass using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to The Biotech Capital Compass?
Scroll up to where it says Similar Newsletters to see other publications like The Biotech Capital Compass. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Biotech Capital Compass?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.